Kuzbass microbiology scientists have become holders of a patent for the technology of obtaining a substance that stimulates bifidobacteria of a particular person.
Another patent secures the copyright for the technology of obtaining exopolysaccharides of normal microflora to the scientists of Kemsu. The scientists' developments are aimed at finding new biological substances that can become the basis of modern antibacterial, anti-inflammatory and immunocorrecting drugs.
Currently, the connection of microbiota with a large number of diseases has been proven: with the development of rectal cancer, diabetes mellitus and autoimmune diseases. According to scientists, it is beneficial bacteria that can support human health, thereby reducing the risk of a number of pathologies.